Carmustine medac (previously Carmustine Obvius) สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustin - hodgkin disease; lymphoma, non-hodgkin - antineoplastiske midler - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Coldostin 4.800.000 IE/g pulver til anvendelse i drikkevand/mælk เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

coldostin 4.800.000 ie/g pulver til anvendelse i drikkevand/mælk

dopharma research b.v. - colistinsulfat - pulver til anvendelse i drikkevand/mælk - 4.800.000 ie/g - får, fjerkræ, kvæg, svin

Colfive 5.000,000 IE/ml koncentrat til oral opløsning เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

colfive 5.000,000 ie/ml koncentrat til oral opløsning

livisto int´l s.l. - colistinsulfat - koncentrat til oral opløsning - 5.000,000 ie/ml - får, fjerkræ, kvæg, svin